athenahealth acquisition for $17bn by Hellman & Friedman

By Helen Adams
Healthcare tech company, athenahealth, to be acquired by Hellman & Friedman and Bain Capital for $17bn, for its accessible and sustainable healthcare

Athenahealth, a provider of cloud-based enterprise software solutions has today declared that it has entered into an agreement to be jointly acquired by affiliates of Bain Capital and Hellman & Friedman, for $17bn. 

The investment is expected to be completed in the first quarter of 2022, subject to regulatory approvals.

 

SaaS technology and the cloud deliver optimal healthcare solutions

Athenahealth, founded in 1997, Massachusetts, USA, is present across all 50 states. The company uses SaaS technology to offer customers access to the athenaOne cloud platform, with modules including:

  • Patient engagement
  • Revenue cycle
  • Telehealth
  • Payments
  • Population health
  • Value-based care management

 

Accessible and sustainable healthcare 

Bob Segert, chairman and CEO of athenahealth, will continue his position with the present management team following the acquisition.

“Today marks a significant milestone for athenahealth and our partnership with Veritas Capital and Evergreen Coast Capital, and we are thrilled to work with Hellman & Friedman and Bain Capital to drive the next phase of our growth journey”, said Segert. “Our employees, customers, and partners are the source of our success and inspiration as we create a thriving ecosystem that delivers accessible, high-quality, and sustainable healthcare for all.” 

“athenahealth’s technology leadership has differentiated the company as a next generation cloud-based SaaS technology platform, facilitating innovation in a rapidly evolving and dynamic market”, said Sameer Narang, partner at Hellman & Friedman.

“athenahealth is at the frontier of digital health in the United States, enhancing the clinical quality, operational efficiency, and delivery of preventive care to nearly 20% of the population today, unlocking the front door of the consumer healthcare journey and positioning the Company to support physicians in the continuing shift towards value-based care”, said Devin O’Reilly, a managing director at Bain Capital Private Equity. “We are excited to leverage our extensive vertical software and healthcare experience to help Bob and the management team accelerate growth, develop new products, gain market share, and continue to innovate in a highly scalable and vitally important end market”, added David Humphrey, a managing director at Bain Capital Private Equity.

Share

Featured Articles

Vaccine Breakthrough on Antibiotics Resistant Diseases

As researchers report breakthrough on vaccine against MRSA bacteria, we look at which pharmas are working on vaccines to combat antimicrobial resistance

Oracle Fusion Cloud Update Boost for Patients

Oracle Fusion Cloud SCM includes new Healthcare Marketplace solution to help hospitals & clinics optimise planning, automate processes and improve outcomes

WHO Tightens air Quality Guidelines as Pollution Kills 7mn

World Health Organisation tightens air pollution guidelines to safeguard health; COVID prompts WHO to redefine 'air-borne' as it relates to diseases

WHO Health Chatbot Built on 'Humanised' GenAI

Digital Healthcare

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Medical Devices & Pharma

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

Medical Devices & Pharma